Table 1.
Characteristics and treatment in all reported patients with crystalline arthropathy in TKA.
| Author | Age (yr) | Sex | Time after TKA | Affected side | History of gout/pseudogout | Diagnosis | Associated infection | Surgical treatment? | Medical treatment | Final follow-up | Successful outcome?a |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Williamson et al. [5] | 86 | F | 10 y | Left | N/a | Gout | No | Y | Colchicine, allopurinol | 1 y | Y |
| Blyth et al. [6] | 58 | M | 4 y | Right | Y | Gout | Staphylococcus aureus | Y | Antibiotics | N/a | N |
| 52 | M | 3 d | Right | Y | Gout | No | N | NSAIDs, colchicine, allopurinol | 1 y | Y | |
| Archibeck et al. [7] | 66 | M | 10 and 12 y | Bilateral | N | Gout | No | Y | Colchicine, allopurinol | 5 mo | Y |
| 88 | F | 9 y | Left | Y | Gout | No | Y | Colchicine | 4 mo | Y | |
| Crawford et al. [8] | 59 | F | 3 mo | Left | N | Gout | No | N | NSAIDs, allopurinol | 1 y | Y |
| Salin et al. [9] | 50s | F | 4 and 4 y | Bilateral | N | Gout | No | Y | Allopurinol, steroids | 1 mo | Y |
| 80s | F | 11 y | Left | Y | Gout | Escherichia coli | Y | Antibiotics, NSAIDs | N/a | Y | |
| Berger et al. [10] | 39 | M | 4 y | Right | Y | Gout | No | Y | NSAIDs, colchicine | N/a | Y |
| Fokter et al. [11] | 68 | M | 11 mo | Left | N/a | Gout | No | N | NSAIDs, allopurinol | 1 wk | Y |
| Freehill et al. [12] | 77 | F | 10 y | Right | Y | Gout | Escherichia coli | Y | Antibiotics | 8 wk | Y |
| Partridge et al. [15] | 66 | F | 8 y | Right | Y | Gout | No | Y | Antibiotics, steroids | 1 y | Y |
| Chen et al. [14] | 43 | M | 7 y | Left | Y | Gout | No | N | Colchicine, allopurinol, steroids | 1 y | Y |
| 72 | M | 10 y | Right | Y | Gout | No | N | Steroids | 5 mo | Y | |
| Yahia et al. [19] | 72 | F | 31 d | Left | N/a | Gout | No | N | Colchicine | N/a | N/a |
| Zadaka et al. [13] | 58 | F | 7 y | Right | N | Gout | No | N | Steroids, allopurinol | 2 d | Y |
| 77 | M | 13 and 20 y | Bilateral | N | Gout/Pseudogout | No | N | Anitibiotics | "several days" | Y | |
| Levi et al. [16] | 70 | F | 8 y | Bilateral | N/a | Pseudogout | No | Y | Antibiotics, steroids | 16 mo | Y |
| Koyama et al. [17] | 64 | F | 13 d | Right | N | Pseudogout | No | N | NSAIDs | 1 y | Y |
| 81 | M | 2 wk | Left | N | Pseudogout | No | N | NSAIDs | 1 y | Y | |
| Harato et al. [18] | 85 | M | 15 d | Right | Y | Pseudogout | No | N | NSAIDs | 1 y | Y |
| Yahia et al. [19] | 79 | M | 7 d | Right | N/a | Pseudogout | No | N | Colchicine | N/a | N/a |
| 73 | F | 3 y | Right | N/a | Pseudogout | No | N | NSAIDs | N/a | N/a | |
| 67 | M | 9 y | Right | N/a | Pseudogout | No | N | Steroids, colchicine | N/a | N/a | |
| 77 | F | 15 d | Right | N/a | Pseudogout | Campylobacter fetus | N | Antibiotics | N/a | N/a | |
| Holt et al. [20] | 72 | M | 2 y | Left | N | Pseudogout | No | Y | NSAIDs | 1 wk | Y |
| Hirose et al. [21] | 59 | F | 7 d | Right | Y | Pseudogout | No | N | NSAIDs | 1 y | Y |
| Sonsale et al. [22] | 69 | F | 10 y | Right | N | Pseudogout | No | N | NSAIDs | 8 y | Y |
NSAIDs, nonsteroidal anti-inflammatory drugs.
Successfwl outcome defined as no recurrence of presenting symptoms.